Benefits of using non-invasive ventilation in the treatment of acute respiratory failure with COVID-19

Abstract

Proper patient selection is a key factor in achieving NIV success. In case of complication of COVID-19 by acute respiratory failure, patients with hypercapnia and moderate respiratory acidosis are most suitable, though the combination of respiratory and metabolic acidosis also responds well to NIV therapy. The main goal of our study was to determine the benefits of NIV in patients with СOVID-19. NIV has obvious advantages over mechanical ventilation. Nevertheless, consideration must be given to a circumstaince that even in experienced hands NIV is successful only in 75-90% of all cases, that depends on many factors, such as the severity of ONE, qualification and experience of medical staff. As with many types of therapy, operations and technologies, the improvement of results of this method can be expected as experience is gained.